Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/10118
Title: GPR18 Inhibiting Amauromine and the Novel Triterpene Glycoside Auxarthonoside from the Sponge-Derived Fungus Auxarthron reticulatum
Authors: Nazir, M.
Harms, H.
Loef, I.
Kehraus, S.
El Maddah, F.
Arslan, İdris.
Rempel, V.
Keywords: Auxarthron reticulatum
GPR18 receptor inhibition
marine-derived fungi
Onygenaceae
amauromine
auxarthonoside
cannabinoid 1 receptor antagonist
G protein coupled receptor
G protein coupled receptor 18
G protein coupled receptor 55
piperazinedione
plant glycoside
triterpene
unclassified drug
alkaloid
cannabinoid 1 receptor
cannabinoid 2 receptor
cannabinoid receptor antagonist
glycoside
GPR18 protein, human
indole derivative
animal cell
Article
carbon nuclear magnetic resonance
CHO cell line
controlled study
drug receptor binding
electrospray mass spectrometry
fungus
heteronuclear multiple bond correlation
IC50
nonhuman
nuclear Overhauser effect
proton nuclear magnetic resonance
receptor blocking
sponge (Porifera)
structure activity relation
animal
antagonists and inhibitors
Ascomycetes
chemical structure
chemistry
human
isolation and purification
microbiology
Fungi
Alkaloids
Animals
Ascomycota
Cannabinoid Receptor Antagonists
Glycosides
Humans
Indoles
Molecular Structure
Porifera
Receptor, Cannabinoid, CB1
Receptor, Cannabinoid, CB2
Receptors, G-Protein-Coupled
Triterpenes
Publisher: Georg Thieme Verlag
Abstract: The marine sponge-derived fungus Auxarthron reticulatum produces the cannabinoid receptor antagonist amauromine (1). Recultivation of the fungus to obtain further amounts for more detailed pharmacological evaluation of 1 additionally yielded the novel triterpene glycoside auxarthonoside (2), bearing, in nature, a rather rare sugar moiety, i.e., N-acetyl-6-methoxy-glucosamine. Amauromine (1), which inhibited cannabinoid CB1 receptors (Ki0.178µM) also showed antagonistic activity at the cannabinoid-like orphan receptor GPR18 (IC50 3.74µM). The diketopiperazine 1 may thus serve as a lead structure for the development of more potent and selective GPR18 antagonists, which are required to study the orphan receptor's potential as a new drug target. Despite the execution of many biological assays, to date, no bioactivity could be found for auxarthonoside (2). © Georg Thieme Verlag KG Stuttgart · New York.
URI: https://hdl.handle.net/11499/10118
https://doi.org/10.1055/s-0035-1545979
ISSN: 0032-0943
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Teknoloji Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record



CORE Recommender

SCOPUSTM   
Citations

17
checked on Feb 24, 2024

WEB OF SCIENCETM
Citations

19
checked on Jul 10, 2024

Page view(s)

16
checked on May 27, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.